Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

[1]  H. Krumholz,et al.  Glucometrics in Patients Hospitalized With Acute Myocardial Infarction: Defining the Optimal Outcomes-Based Measure of Risk , 2008, Circulation.

[2]  N. Weissman,et al.  A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE). , 2008, American heart journal.

[3]  M. Ishihara,et al.  Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. , 2007, The American journal of cardiology.

[4]  Andrew S. Holmes,et al.  The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. , 2007, Journal of the American College of Cardiology.

[5]  Daniel S. Berman,et al.  Myocardial perfusion and function: Single photon emission computed tomography , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[6]  C. Tei,et al.  Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. , 2005, American heart journal.

[7]  C. Tei,et al.  Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[8]  A. Jaffe,et al.  The quantification of infarct size. , 2004, Journal of the American College of Cardiology.

[9]  R. Heine,et al.  Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. , 2004, Archives of internal medicine.

[10]  A. Ceriello,et al.  Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects , 1993, Diabetologia.

[11]  K. Nishioka,et al.  Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. , 2003, American heart journal.

[12]  A. Takeshita,et al.  Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. , 2003, Journal of the American College of Cardiology.

[13]  M. Hori,et al.  Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[14]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[15]  M. Löndahl,et al.  Cardiovascular prevention before admission reduces mortality following acute myocardial infarction in patients with diabetes , 2002, Journal of internal medicine.

[16]  P. Pagel,et al.  Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. , 2001, American journal of physiology. Heart and circulatory physiology.

[17]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[18]  S. Kaul,et al.  Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease. , 2000, Journal of the American College of Cardiology.

[19]  A J Sinusas,et al.  Quantification of SPECT myocardial perfusion images: Methodology and validation of the Yale-CQ method , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[20]  Farris K. Timimi,et al.  Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. , 1998, Circulation.

[21]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[22]  S. Fava,et al.  The Prognostic Value of Blood Glucose in Diabetic Patients with Acute Myocardial Infarction , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[23]  J Col,et al.  Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.

[24]  R. Conroy,et al.  In-Hospital Prognosis of Ppatients With Fasting Hyperglycemia After First Myocardial Infarction , 1991, Diabetes Care.

[25]  L. Muratori,et al.  Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. , 1989, The American journal of cardiology.

[26]  P. Becker,et al.  Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. , 1989, The Quarterly journal of medicine.

[27]  Opie Lh,et al.  Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. , 1986 .

[28]  J. Yudkin,et al.  Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. , 1986, British medical journal.

[29]  K. Thygesen,et al.  Altered plasma concentrations of glutamate, alanine and citrate in the early phase of acute myocardial infarction in man. , 1986, European heart journal.

[30]  J. Yudkin,et al.  PREVALENCE AND RISKS OF HYPERGLYCAEMIA AND UNDIAGNOSED DIABETES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION , 1984, The Lancet.